Healthy Volunteers Clinical Trial
Official title:
Reliability and Validity of a Shoulder Fatigue Test Using Two Tools: Elastic Resistance and Isokinetic Dynamometer.
Introduction: The exercise performed with elastic tools has been appearing in the current scenario as a clinical tool because it presents advantages such as easy handling, low cost and safety. However, its use as an assessment tool, specifically for localized muscular resistance, is reduced and not standardized. In addition, there are no records of the physiological / neurofunctional effects of tests that use such a tool, since it allows a differentiated degree of prescription. Objective: To determine the reliability and reproducibility of a shoulder abduction resistance test in two tools, elastic tube and isokinetic dynamometer. In addition to analyzing the metabolic profile of both comparative order and targeting subsequent training prescription. Method: The study will consist of a sample of 30 participants and will be carried out in 2 stages, 15 participants will perform step 1 and the other 15 will perform step 2. The difference between the steps is the order of the tools used to perform the test . Each stage will consist of 5 sessions (Orientation, Familiarization 1 and 2, Test and Retest). During the test and retest sessions the physiological response of the test will be analyzed. In order to observe the response, will be analyzed the lactic anaerobic parameter (lactate concentration), allelic anaerobic (post-exercise oxygen uptake analysis - EPOC), aerobic parameter (VO2 values) and electromyographic measurements. Will be used the statistical package SPSS Statistics 22.0, Pearson's correlation and their respective confidence intervals will indicate the relationship between the numerical variables and multivariate models will be constructed by means of linear regression. The significance level of 5% will be adopted.
Tests applied
1RM test The 1 RM test in the elastic band is based on the study by ANDERSEN et al. (2016).
Elastic bands of the brand Theraband® CLX (Hygienic, Corporation, Akron, Ohio, USA) with a
standard length of 1.47m, ranging from very low to very high strength (yellow, red, green,
blue, black, silver, gold). Due to possible changes in the mechanical properties of elastic
bands during the initial stretching cycles, all elastics will be pre-stretched 100 times.
Initially the research assistant will instruct the participants to sit on a chair, and place
their feet together on the elastic band without shoes. Starting with the least elastic
resistance (yellow), the research assistant will instruct the participants to perform a
shoulder abduction of a unilateral (dominant) shoulder up to 90 ° and hold such a position
for 3 seconds (statically). Thus, participants will have to perform the concentric
contraction phase without the help of the research assistant before reaching the static test
position. Through visual inspection, the search assistant will control the correct
positioning of the movement. Two-minute intervals will be taught between resistance levels
until it is not possible for the participant to reach and / or hold the position for 3
seconds. When there is a failure, two more attempts to reach and maintain the desired
position will be accomplished. During the essay, the research assistant will provide verbal
encouragement. The obtained torque will be calculated by a formula based on the study of
ANDERSEN et al. (2016).
Isokinetic muscle strength test For the MVIC test, the participant will be seated with the
dominant upper limb on the Biodex System Pro 4 isokinetic dynamometer (Biodex Medical System,
Shirley-NY, USA). Prior to the test, the participant will undergo a warm-up consisting of 10
repetitions of concentric contraction of abduction-adduction of the shoulder at 180º / s
throughout the range of motion. After the warm-up will be given a two-minute rest break to
the start of the MVIC. The CIVM will be considered as the Of torque obtained between three 5
second repetitions of abduction, with the dominant upper limb positioned at 90º horizontal
abduction of the shoulder. A two-minute interval between replicates will be administered in
order to minimize possible fatigue effects. The participant will be instructed to perform
their maximum power performance and will be verbally encouraged by the evaluator in each
attempt made. Such protocol is based on the one used by BARONI et al., (2010) for lower limb.
Fatigue Resistance Test (TRF) TRF - Elastic Tube: To perform the fatigue resistance test on
the elastic tube the participant will initially be positioned sitting on a chair with their
feet together stepping on the elastic band without shoes. He will then perform a 20-second
abduction-adduction heating of the shoulder from the neutral position to 90 °. The interval
of 2 minutes will then be given to start the TRF. This will consist of performing the maximum
of the possible repetition with a load of 50% of the 1RM (1½ second in the concentric phase
and 1½ second in the eccentric phase).
TRF - Isokinetic Dynamometer: In order to perform the fatigue resistance test in the
isokinetic dynamometer, the participant will initially be positioned with the dominant upper
limb attached to the dynamometer by means of the apparatus itself. He will then perform a
warm-up of 10 concentric contractions of abduction-adduction of the shoulder at 180º / s
throughout the range of movement (0º to 90º). The interval of 2 minutes will then be given to
start the TRF. This will consist of performing the maximum possible repetition at 50% of the
MVIC at the rate of 60º / s for abduction and 500º / s at the return of the movement.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |